Chung‐Kyu Ryu

1.4k total citations
67 papers, 1.3k citations indexed

About

Chung‐Kyu Ryu is a scholar working on Organic Chemistry, Toxicology and Molecular Biology. According to data from OpenAlex, Chung‐Kyu Ryu has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Organic Chemistry, 38 papers in Toxicology and 16 papers in Molecular Biology. Recurrent topics in Chung‐Kyu Ryu's work include Bioactive Compounds and Antitumor Agents (38 papers), Synthesis and biological activity (27 papers) and Synthesis and Biological Evaluation (13 papers). Chung‐Kyu Ryu is often cited by papers focused on Bioactive Compounds and Antitumor Agents (38 papers), Synthesis and biological activity (27 papers) and Synthesis and Biological Evaluation (13 papers). Chung‐Kyu Ryu collaborates with scholars based in South Korea, Japan and Germany. Chung‐Kyu Ryu's co-authors include Jung Yoon Lee, Yeo‐Pyo Yun, Kwang‐Hoe Chung, M. J. Chae, Yong-Ri Jin, Heejeong Kim, Ja‐Young Han, Mi‐Ra Cho, Aram Kim and Sung‐Yu Hong and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Chung‐Kyu Ryu

65 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chung‐Kyu Ryu South Korea 23 900 410 390 109 71 67 1.3k
Li‐Jiau Huang Taiwan 21 1.0k 1.2× 280 0.7× 723 1.9× 164 1.5× 58 0.8× 65 1.8k
Andrey E. Shchekotikhin Russia 22 608 0.7× 388 0.9× 1.1k 2.8× 177 1.6× 69 1.0× 150 1.7k
Shaoshun Li China 24 653 0.7× 473 1.2× 722 1.9× 206 1.9× 100 1.4× 84 1.6k
Aisha A. Alsfouk Saudi Arabia 19 696 0.8× 189 0.5× 662 1.7× 50 0.5× 33 0.5× 92 1.3k
David E. Zembower United States 16 481 0.5× 195 0.5× 645 1.7× 170 1.6× 11 0.2× 26 1.1k
Shagufta Shagufta India 16 591 0.7× 77 0.2× 309 0.8× 114 1.0× 12 0.2× 39 1.0k
Simona Musella Italy 18 388 0.4× 58 0.1× 402 1.0× 64 0.6× 22 0.3× 43 921
Guillaume Le Baut France 18 612 0.7× 112 0.3× 280 0.7× 101 0.9× 20 0.3× 77 1.0k
Forrest Smith United States 16 143 0.2× 190 0.5× 203 0.5× 134 1.2× 33 0.5× 46 686
Subhas S. Karki India 21 638 0.7× 66 0.2× 696 1.8× 52 0.5× 29 0.4× 80 1.5k

Countries citing papers authored by Chung‐Kyu Ryu

Since Specialization
Citations

This map shows the geographic impact of Chung‐Kyu Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Kyu Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Kyu Ryu more than expected).

Fields of papers citing papers by Chung‐Kyu Ryu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung‐Kyu Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Kyu Ryu. The network helps show where Chung‐Kyu Ryu may publish in the future.

Co-authorship network of co-authors of Chung‐Kyu Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Chung‐Kyu Ryu. A scholar is included among the top collaborators of Chung‐Kyu Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung‐Kyu Ryu. Chung‐Kyu Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryu, Chung‐Kyu, et al.. (2017). Induction of immunogenic cell death of tumors by newly synthesized heterocyclic quinone derivative. PLoS ONE. 12(3). e0173121–e0173121. 8 indexed citations
2.
Ryu, Chung‐Kyu, et al.. (2010). Synthesis and antifungal activity of benzofuran-5-ols. Bioorganic & Medicinal Chemistry Letters. 20(22). 6777–6780. 42 indexed citations
3.
Ryu, Chung‐Kyu, et al.. (2008). Design, synthesis and evaluation of 2-phenyl-1H-benzo[d]imidazole-4,7-diones as vascular smooth muscle cell proliferation inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(9). 2948–2951. 2 indexed citations
4.
Ryu, Chung‐Kyu, et al.. (2007). Synthesis and antifungal activity of 6-arylamino-phthalazine-5,8-diones and 6,7-bis(arylthio)-phthalazine-5,8-diones. Bioorganic & Medicinal Chemistry Letters. 17(9). 2577–2580. 152 indexed citations
5.
Kim, Jin Sung, Hyen Joo Park, Sang Kook Lee, et al.. (2006). Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity. Bioorganic & Medicinal Chemistry. 15(1). 451–457. 27 indexed citations
6.
Ryu, Chung‐Kyu, et al.. (2006). Synthesis and antifungal activity of 1H-indole-4,7-diones. Bioorganic & Medicinal Chemistry Letters. 17(1). 127–131. 47 indexed citations
7.
Ryu, Chung‐Kyu, et al.. (2005). Synthesis and antifungal activity of 5-arylamino-4,7-dioxobenzo[b]thiophenes. Bioorganic & Medicinal Chemistry Letters. 15(10). 2617–2620. 35 indexed citations
8.
Ryu, Chung‐Kyu & M. J. Chae. (2005). Synthesis and antifungal activity of naphthalene-1,4-diones modified at positions 2, 3, and 5. Archives of Pharmacal Research. 28(7). 750–755. 15 indexed citations
9.
Ryu, Chung‐Kyu, et al.. (2005). Synthesis and antifungal activity of 2/3-arylthio- and 2,3-bis(arylthio)-5-hydroxy-/5-methoxy-1,4-naphthoquinones. European Journal of Medicinal Chemistry. 40(5). 438–444. 44 indexed citations
10.
Park, Hyen Joo, Young-Shin Kim, Jin Sung Kim, et al.. (2004). 6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents. Bioorganic & Medicinal Chemistry Letters. 14(13). 3385–3388. 29 indexed citations
11.
12.
Choo, Hea‐Young Park, et al.. (2003). QSAR study of quinolinediones with inhibitory activity of endothelium-Dependent vasorelaxation by CoMSIA. Bioorganic & Medicinal Chemistry. 11(9). 2019–2023. 3 indexed citations
13.
Ryu, Chung‐Kyu, et al.. (2003). Synthesis and antifungal activity of 2,5-disubstituted-6-arylamino-4,7-benzimidazolediones. Bioorganic & Medicinal Chemistry Letters. 13(1). 17–20. 28 indexed citations
14.
Kim, Jung‐Sun, et al.. (2002). Purification and Characterization of a Cytosolic, 42-kDa and Ca2+-dependent Phospholipase A2from Bovine Red Blood Cells. Journal of Biological Chemistry. 277(23). 21086–21094. 11 indexed citations
15.
Ryu, Chung‐Kyu, et al.. (2001). 7-(Substituted-phenyl)amino-5,8-quinazolinediones: Potent inhibitors of endothelium-dependent vasorelaxation. Medicinal Chemistry Research. 10(9). 605–614. 1 indexed citations
16.
17.
Zhang, Yonghe, Kwang-Hoe Chung, Chung‐Kyu Ryu, et al.. (2001). Antiplatelet Mechanism of 2-Chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone (NQ304), an Antithrombotic Agent. Pharmacology & Toxicology. 88(4). 181–186. 4 indexed citations
18.
Ryu, Chung‐Kyu, Jin‐Tae Hong, Kwang‐Hoe Chung, et al.. (2000). Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative. Biochemical Pharmacology. 60(7). 1001–1008. 53 indexed citations
19.
Ryu, Chung‐Kyu, et al.. (1999). Antiplatelet and Antithrombotic Activities of NQ301, 2-Chloro-3-(4-acetophenyl)-amino-1,4-naphthoquinone.. Biological and Pharmaceutical Bulletin. 22(12). 1284–1287. 8 indexed citations
20.
Ryu, Chung‐Kyu & Dong‐Hyun Kim. (1994). The antifungal activities of some 6-[N-(halophenyl)amino]-7-chloro-5,8-quinolinediones againstCandida species. Archives of Pharmacal Research. 17(6). 483–6. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li‐Jiau Huang Breakdown of academic impact, for papers by Andrey E. Shchekotikhin Breakdown of academic impact, for papers by Shaoshun Li Breakdown of academic impact, for papers by Aisha A. Alsfouk Breakdown of academic impact, for papers by David E. Zembower Breakdown of academic impact, for papers by Shagufta Shagufta Breakdown of academic impact, for papers by Simona Musella Breakdown of academic impact, for papers by Guillaume Le Baut Breakdown of academic impact, for papers by Forrest Smith Breakdown of academic impact, for papers by Subhas S. Karki
Rankless by CCL
2026